Dasatinib tablet is an anti-cancer medicine. It is prescribed during the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia a blood cancer cell.
Dasatinib 50 mg tables stops the growth of chronic myeloid leukemia and acute lymphoblastic leukemia cells. Patients are advised to crush, chew, or break the tablet while consuming orally. During pregnancy or breastfeeding, patients are not advised to consume without consulting the doctor. If patients have disease in hte liver, heart, or kidney inform the doctor at the beginning of treatment.